Business and other management consultancy activities
NORDIC BIOTECH AS
Revenue 2024
NOK 0
Operating profit
NOK −20,000
Equity
NOK −59,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.91
Equity ratio
-42.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -14.2% | |
| Likviditet | ||
| Current ratio | 0.91 | |
| Working capital | −9k | |
| Soliditet | ||
| Equity ratio (%%) | -42.4% | |
| Debt-to-equity ratio | -3.36 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.